Clinical Trial Update: Surveillance of Treatment of Children With Growth Hormone Deficiency With Zomacton®

View source ↗

Summary

The pediatric trial evaluating the use of Zomacton (somatropin) for growth hormone deficiency has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Growth Hormone Deficiency

Drugs mentioned

• ZOMACTON (Somatropin)

Snippet

Sponsor: Ferring Pharmaceuticals | Conditions: Growth Hormone Deficiency | Status: WITHDRAWN